Madlon-Kay D J
Department of Family and Community Medicine, St Paul Ramsey Medical Center, Minn, USA.
Arch Fam Med. 1996 Apr;5(4):234-6. doi: 10.1001/archfami.5.4.234.
To determine if a mail reminder system leads to an increase in the percentage of depot medroxyprogesterone acetate (Depo-Provera) injections administered on time, the charts of 184 women were reviewed. The reminder postcard included the due dates of both the next medroxyprogesterone injection and the next Papanicolaou test. Timeliness of injections improved with the reminder system from 64% administered on time to 76% (P < .02). Injections given late despite the reminders were late a mean of 8 days. Injections given late before the reminder system began were late a mean of 20 days (P < .05). If injections given during the injection's 14-day "grace" period are included, the on-time rate improved from 87% to 96% with the reminder system (P < .005). The reminder system was not effective in ensuring annual Papanicolaou testing. Vigilance is needed to ensure that women receiving medroxyprogesterone injections also receive timely Papanicolaou testing.
为确定邮件提醒系统是否会提高醋酸甲羟孕酮(Depo-Provera)注射按时给药的比例,研究人员查阅了184名女性的病历。提醒明信片包含下次甲羟孕酮注射和下次巴氏试验的到期日期。使用提醒系统后,注射的及时性从按时给药的64%提高到了76%(P < 0.02)。尽管有提醒但仍延迟注射的平均延迟时间为8天。在提醒系统开始之前延迟注射的平均延迟时间为20天(P < 0.05)。如果将在注射的14天“宽限期”内进行的注射包括在内,使用提醒系统后按时给药率从87%提高到了96%(P < 0.005)。提醒系统在确保年度巴氏试验方面无效。需要保持警惕,以确保接受甲羟孕酮注射的女性也能及时接受巴氏试验。